What is the long-term trend for MiMedx Group's commissions and contract termination costs?

Over 5 years (2020 to 2025), MiMedx Group's commissions and contract termination costs has grown at a 20.3% compound annual growth rate (CAGR), from $2.14M to $5.39M.

MiMedx Group MDXG Commissions and Contract Termination Costs

Commissions and Contract Termination Costs at other companies

Establishment LabsESTA

——

Other financials

Income statement

See full

Revenue$59.0M-33.1%

Gross profit$41.6M-41.9%

Operating income-$16.0M-295%

Net income-$10.9M-255%

EPS (diluted)-$0.07-240%

Balance sheet

See full

Cash & equivalents$159.8M+50.1%

Total debt$17.6M-5.7%

Total equity$242.9M+19.8%

Total assets$308.7M+14.1%

Cash flow

See full

Operating cash flow$1.9M-64.5%

CapEx$570.0K+51.2%

Free cash flow$1.3M-73.4%

Valuation

See full

Market cap$567.48M-33.9%

Enterprise value$425.3M-44.8%

P/E18.5×-2.9×

P/S1.5×-1.0×

Profitability

See full

Gross margin81%-0.9pp

Operating margin10.2%-5.1pp

Net margin7.9%-3.5pp

FCF margin17.8%-0.5pp

Returns & leverage

See full

Return on equity13.8%-8.6pp

Debt / equity0.1×0.0×

Current ratio5.4×+0.7×

Where this comes from

Reported directly by MiMedx Group in its filing.

Tagged under the XBRL concept us-gaap:AccruedSalesCommissionCurrent.

The official record: MiMedx Group’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about MiMedx Group's commissions and contract termination costs.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is MiMedx Group's commissions and contract termination costs?: MiMedx Group (MDXG) reported commissions and contract termination costs of $4.45M in Q1 2026.
How has MiMedx Group's commissions and contract termination costs changed year-over-year?: MiMedx Group's commissions and contract termination costs increased by 19.0% year-over-year, from $3.74M to $4.45M.
What is the long-term trend for MiMedx Group's commissions and contract termination costs?: Over 5 years (2020 to 2025), MiMedx Group's commissions and contract termination costs has grown at a 20.3% compound annual growth rate (CAGR), from $2.14M to $5.39M.